Trials / Completed
CompletedNCT00042588
A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- ICOS Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to demonstrate the safety and efficacy of IC14 in the treatment of hospitalized patients with community-acquired pneumonia and sepsis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Recombinant Chimeric Monoclonal Antibody |
Timeline
- Start date
- 2002-05-01
- First posted
- 2002-08-05
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00042588. Inclusion in this directory is not an endorsement.